Clinical trial
A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
NCT05279456 is registered in ClinicalTrials.gov with Vaxine Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
- Lead sponsor
- Vaxine Pty Ltd
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 15, 2022
- Completion date
- December 31, 2023
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.